OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-03-31-accounts

Report and Financial Statements St. Gemma's Hospice Always caring For the year ended 31st March 2024 Company Registration No: 02773867 Charity Registration No: 1015941

----- Start of picture text -----
Reference and administrative information 3
Leadership Team 4
Board of Trustees 5
Vision, values and strategy 6
Statement from the Chair of the Board of Trustees and the Chief Executive 7-9
Strategic Highlights 10-11
Patient Story 12
Strategic Report 13
The Year Under Review 14-20
Looking Ahead 21
Financial Review 22-25
Structure, Governance and Management 26-29
Independent auditor’s report 30-33
34-35
Consolidated statement of financial activities
Balance Sheets 36
Consolidated cash flow statement 37
Statement of accounting policies 38-41
42-55
Notes to the group financial statements
----- End of picture text -----

2

Trustees’ Report 2023/24

Reference and

Administrative Information

Charity Name St Gemma’s Hospice

Charity Registration Number 1015941

Bankers

HSBC Bank plc 33 Park Row Leeds LS1 1LD

Company Registration Number 02773867

Registered Office

329 Harrogate Road Moortown Leeds LS17 6QD

Patrons

Investment Advisers

Rathbones 2 Gresham Street London EC2V 7QN

Auditor

Saffery LLP 10 Wellington Place Leeds LS1 4AP

The Right Rev Marcus Stock, Catholic Bishop of Leeds The Right Rev Nick Baines, Anglican Bishop of Leeds HM Lord-Lieutenant for West Yorkshire, Ed Anderson

The Earl and Countess of Harewood Professor Gerald Richards Tom Riordan CBE Arif Ahmad Zulfi Hussain MBE Marilyn Stowe Henry Cohen

3

Trustees’ Report 2023/24

Hospice Leadership Team

Kerry Jackson OBE Chief Executive

Jason Kirk

Chief Operating Officer and Company Secretary

Dr Mike Stockton Consultant in Palliative Medicine and Chief Medical Officer

Kate Goldring Director of Income Generation

Heather McClelland Chief Nurse

4

Trustees’ Report 2023/24

Board of Trustees

Philomena Corrigan Chair of the Board of Trustees

Dr Jonathan Smith

Deputy Chair of the Board Chair of the Corporate Governance Committee from March 2024

Kim Gay

Chair of the Finance and Business Committee from June 2024 Member of the Corporate Governance Committee from June 2024

Reverend Barry Miller

Spiritual Care Champion Member of the Clinical and Academic Governance Committee

Mukesh Parekh

Member of the Finance and Business Committee from September 2023

Brigid Reid Member of the Clinical and Academic Governance Committee

Lucy Ziegler

Jacqueline Murphy

Chair of the Clinical and Academic Governance Committee Member of the Corporate Governance Committee

Hilary Barrett

Member of the Finance and Business Committee

Dr Eileen Burns

Member of the Clinical and Academic Governance Committee

Kim Halliday

Member of the Finance and Business Committee from June 2024

Lisa Hollidge

Member of the Finance and Business Committee from September 2023

Anna Kerruish

Member of the Finance and Business Committee from June 2024

Bassem Keir

Member of the Finance and Business Committee from September 2023

University of Leeds Representative Member of the Clinical and Academic Governance Committee from June 2024

Sr Anne Hammersley CP

Representative of the Sisters of the Cross and Passion Charitable Incorporated Organisation Until July 2024

Professor Sir Alex Markham

University of Leeds Representative Member of the Clinical and Academic Governance Committee Retired March 2024

Angus Martin

Chair of the Finance and Business Member of the Corporate Governance Committee. Retired March 2024

Dr Mohammed Sattar

Member of the Clinical and Academic Governance Committee Resigned October 2023

Chris Schofield Chair of the Corporate Governance Committee Resigned September 2023

5

Trustees’ Report 2023/24

Vision, Values and Strategy

----- Start of picture text -----
Hospice St Gemma’s Hospice
----- End of picture text -----

6

Trustees’ Report 2023/24

Statement from the Chair of the Board of Trustees and the Chief Executive

During 2023/24 St Gemma’s Hospice delivered high quality, holistic, evidence-based care to local people facing a terminal illness. We supported their families, carers and loved ones, including the provision of bereavement counselling and support. We improved care for those approaching the end of life through integrated research, teaching and translating evidence into clinical practice.

Patients access St Gemma’s services in many ways, often accessing more than one service over time, including In-Patient care, specialist palliative care at home or support as an Outpatient. This care is provided by our multi-disciplinary team including doctors, nurses, therapists, social workers, spiritual care staff and support staff.

Unique first referrals increased slightly in 2023/24, with increased In-Patient admissions and a rise in the proportion of patients with a diagnosis other than cancer. Our Community medical and nursing staff increased face to face contacts by 9% compared with last year, whilst telephone contacts fell. This reflects the increasingly complex needs of patients and families and the challenges within the wider health and care system.

7

Trustees’ Report 2023/24

Outpatient Group activity levels more than doubled with the introduction of a range of activities and groups suitable for people with different needs and interests.

During the year we opened The Cabin in the Hospice gardens, providing a purpose-built therapeutic environment for children and young people to access bereavement support. Our adult bereavement service developed a new citywide support programme, Growing around Grief, providing six weeks of structured group sessions.

Feedback from patients and families about their experience of St Gemma’s services continued to be excellent, reflecting the hard work, dedication and compassion of our staff and volunteers. We maintained safe, effective, responsive, caring, and well-led services, supporting our Outstanding rating from the Care Quality Commission.

Our quality improvement priorities, as outlined in our published Quality Account, made good progress in 2023/24. This included enhancing safety and access to In-Patient care for patients with a tracheostomy or laryngectomy. Partnership working, through which we seek to ensure improved patient and family outcomes and greater integration of care, included active engagement in the Leeds Palliative Care Network, the Leeds End of Life Population Board, and the West Yorkshire Hospice Collaborative.

Through the Academic Unit of Palliative Care (AUPC), working in partnership with the University of Leeds, we continued to consolidate our position as a centre of excellence. Over 1,000 external healthcare professionals received training from St Gemma’s Academic Unit of Palliative Care, and we hosted 174 students on placement. The Board of Trustees approved our new AUPC Strategy, with ambitious but realistic goals.

The University of Leeds research team has been selected as one of three national centres in the first Policy Research Unit for palliative and end of life care, and we have appointed a Research Practitioner based at the Hospice.

Our commitment to wellbeing and engagement for our dedicated 300 staff and 700 volunteers is supported by effective communications, staff and volunteer engagement groups, Wellbeing Champions, staff supervision, survey feedback, and celebration and recognition events.

8

Trustees’ Report 2023/24

Understanding and responding to the needs of our local community has resulted in the continuation of our work with partners in the city to improve care for the homeless and vulnerably housed and to contribute to the Dying Well in Seacroft project. We have also commenced an engagement project with local Pakistani communities to understand their needs and enhance referrals into Hospice services.

All our services are provided free of charge to patients and those close to them, thanks to the sustained and generous support of donors and our local community, as well as funding support from the NHS. During this year we have worked closely with the West Yorkshire Hospice Collaborative and the West Yorkshire Integrated Care Board as we seek to secure more sustainable NHS funding for all hospices in our region.

Despite a difficult financial environment including wage inflation, significant operational cost increases and the impact of the cost of living on our income generation activities, we continue to be in a strong financial position and remain confident about our long term financial sustainability.

Our total income in 2023/24 of £14m was £1.1m below 2022/23. The most significant movement was the fall in legacy income of £1.3m. Legacy income in 2022/23 was exceptionally high and our legacy receipts in 2023/24 were above budget and above the long term averages. Our Chief Executive has made the difficult decision to step down from her role at the end of the calendar year. The recruitment process for her successor has begun.

We are delighted that Philomena Corrigan continues as Chair of the Board and we welcome our new Trustees: Kim Halliday, Anna Kerruish and Lucy Ziegler. We give grateful thanks to those Trustees who have retired from the Board for their contribution to St Gemma’s: Chris Schofield, Dr Mohammed Sattar, Angus Martin and Professor Sir Alex Markham. As outgoing Chair of the Finance and Business Committee, Angus Martin was on our Board for 10 years in total, extending his term of office to provide additional support during a time of transition on the Board. Our thanks also go to Clare Russell, Director of Transformation and Culture, who resigned during the year.

In addition, we recognise the dedication, skill and kindness of Sister Anne Hammersley. Sister Anne died peacefully in the care of St Gemma’s in July 2024. We are grateful to her as one of

Kerry Jackson Philomena Corrigan Chief Executive Chair of the Board

Trustees’ Report 2023/24 9

Strategic Highlights

External Healthcare Professionals Trained 2022/23 2023/24 1,054 1,013

Volunteer Numbers 2022/23 2023/24 724 749

2022/23 24 Shops

2022/23 663,195

2022/23 1,372,003

Inclusive Top 50 Companies 2022/23 2023/24 31st 23rd

Admissions to In-Patient Unit

2022/23 2023/24 492 503

New Patient Referrals

2022/23 2023/24 1,365 1,382

Cancer: Non-Cancer Patient Referrals

2022/23 2023/24 66%: 34% 63%:37%

Ave

2022/23 12.2

2022/23 301

2023/24 25 Shops

2023/24 697,463

2023/24 1,432,327

2023/24 11.9

2023/24 299

Out-Patient Group Contacts 2022/23 2023/24 918 2,258

NHS Core Grant

2022/23 2023/24 28.4% 30.8%

X (Formerly Twitter) Followers

Community Nursing and Medical Contacts 2022/23 2023/24 19,842 18,742

2022/23 2023/24 8,098 8,100

Facebook Followers

2022/23 2023/24 18,200 18,900

Student Placements

Website Visits

2022/23 2023/24 128 174

2022/23 2023/24 148,000 150,000

Total Income 2022/23[2023/24] £15,059,298 £13,986,626

Patient Story

Liz worked at St Gemma’s Hospice before being diagnosed with leukemia in 2020. She underwent years of treatment, including chemotherapy and a stem cell transplant, which required her to spend extended periods in isolation in hospital. In early 2024, Liz was referred to St Gemma’s community team for support at home.

When Liz’s health and mobility deteriorated, she was admitted to St Gemma’s In-Patient Unit.

Liz said: “I feel like I have come full circle. I worked here and now I’m here for care and support. They aren’t just supporting me - they are looking after my mum and dad, my brother, my husband and my beautiful sons with compassion, understanding and genuine kindness.

“It’s not just the clinical teams, it’s the whole team. We have been able to enjoy time in the beautiful gardens, we have sat in the Hospice Bistro and had amazing family Sunday roasts. The chef even baked me my favourite cake, which was just so thoughtful. I had a very challenging day recently and needed to go outside for some fresh air and to rebalance.

“When I returned to my room, my bed had been changed with beautiful fresh bedding and the team had left me this gorgeous knitted heart on my pillow, saying ‘from us to you.’ These small acts of kindness go such a long way.

“I don’t think you really truly appreciate what hospice care is about until you need it. It is above and beyond. I am being embraced, loved and incredibly cared for by my new ‘family’ here at the Hospice, helping me have more quality time with my life and my own gorgeous family.”

After several weeks at the Hospice, Liz died peacefully, surrounded by her family. She was 42 years old.

Her husband Colin reflected:

Unless you require the services of somewhere like St Gemma’s, you won’t necessarily appreciate the amazing work they do. I didn’t until we needed them and we are so thankful for their tireless efforts. It has made a huge impact and difference to us all.

12

Trustees’ Report 2023/24

Strategic Report

St Gemma’s Hospice is a registered charity.

Our objects are:

All in accordance with the teachings in the catechism of the Roman Catholic Church and pronouncements of the Holy See from time to time on the sanctity of human life.

The Trustees have referred to the Charity Commission’s general guidance on public benefit when reviewing the aims and objectives of the Hospice and in planning future activities which are set out in this report.

Our services are open to patients 18 and over. We provide care to people with a range of diagnoses including cancer, neurological conditions, and end stage respiratory and heart disease. We also provide support to families and carers including children and young people.

The Hospice team provides specialist palliative care, where the patient has unresolved needs that exceed the expertise of the referring team, and end of life care. Care is provided by our specialist team of doctors, nurses, social workers, therapists, counsellors, and spiritual care workers and by our team of vital support staff and volunteers. Much of our care is provided in people’s own homes and care homes, with care also offered in our In-Patient Unit and Outpatient and Day Services in Moortown.

St Gemma’s care is individual and holistic, seeking to alleviate symptoms such as pain and breathlessness as well as supporting people’s emotional and spiritual wellbeing. We recognise the unique physical, emotional, social, and spiritual needs of each person and place a high value on respect, choice and empowerment.

Our services are provided free of charge to patients and those close to them. We receive a proportion of our funding from the NHS, with the remainder coming from the local community, which generously funds us through donations, fundraising and gifts in wills and continues to give thousands of volunteer hours every year.

13

Trustees’ Report 2023/24

The Year Under Review

Ensuring Quality of Care

St Gemma’s aim is to deliver the highest quality care for patients and support for families. We are committed to continuous learning by monitoring performance, looking for any gaps in practice and identifying ways to improve care. Patient and service user feedback continues to be excellent, reflecting the “Outstanding” rating received from the Care Quality Commission in our most recent inspection (2021). During 2023/24 we delivered a robust programme of engagement, collecting feedback across different services and events. Patients and families are often eager to praise the whole team, recognising that every member of the St Gemma’s team supports the provision of patient and family care.

We have seen a small increase in overall activity levels in 2023/24 compared to 2022/23. Face to face community nursing assessments and consultations increased by 9% while telephone contacts fell, reflecting the need for more in person contacts arising from increasingly complex patient needs. Outpatient attendances more than doubled as we continued to embed and develop our revised service offer.

The proportion of patients with a non-cancer diagnosis has again increased, reflecting our commitment to providing effective specialist multi-disciplinary care for patients with non-malignant disease. Our services for the homeless and vulnerably housed have increased in activity and impact and we have begun focused improvement work with our local Pakistani community as part of a broader programme to reduce health inequalities.

Bereavement activity continues to thrive, with a regular Growing around Grief course open to people across the city, the Young People’s Service offering citywide support and The Cabin as a bespoke therapeutic environment for children and young people on the Hospice grounds.

Strategy Review

Our Hospice Strategy runs from 2018 to 2028. Based on our strategy review in 2022 we developed a two-year Business Plan for 2023 to 2025. This included key projects and initiatives to enhance our services and to improve some of our business and technology infrastructure. Many of these projects were progressed successfully through the year.

In addition, following several structured workshops, we revised our Academic Unit of Palliative Care strategy to drive changes for the future, and have already begun work on some key education programmes in particular.

We have amended our Hospice Business Plan for the period 2024 to 2026, as well as agreeing a more outcomes-based approach to service developments and other transformational change programmes. This is outlined in the Looking Ahead section, page 21.

Clinical Quality Improvements

Effective and safe patient care is central to everything we do at St Gemma’s. We monitor care quality and safety using a range of measures and continually seek to improve against the latest research evidence and best practice guidance. The measures include patient outcome metrics, patient and family feedback, complaints, service performance and clinical incident reviews. Our key performance indicators for 2023/24 do not give rise to any significant areas of concern.

We continue to work closely with other health and care providers and with NHS commissioners, to ensure that services are provided in an integrated way to meet patients’ needs and improve outcomes. St Gemma’s is an active member of the Leeds Palliative Care Network, the Leeds End of Life Population Board and the West Yorkshire Hospice Collaborative.

Trustees’ Report 2023/24

14

The St Gemma’s Quality Account sets out our priorities for clinical improvement each year.

The priorities for 2023/24 were:

Hospice Workforce and Culture

Our team of Wellbeing Champions has delivered a number of initiatives supported by our volunteers, staff and external organisations. These included offers such as a pizza van with salad bar, colour analysis sessions, painting class, retail therapy, complementary therapies amongst other initiatives. The Wellbeing Champions group has plans in place for our 2024 wellbeing week, scheduled for October and followed by a staff celebration event.

In May 2023 we held our Staff Awards night in recognition of staff performance throughout the year. This was a successful night supporting our top performers and teams across the Hospice. We are continuing with our quarterly ‘Gem of St Gemma’s’ awards where staff can nominate colleagues for special recognition.

We decided to change our staff survey

provider from the Times Top 100 Best Companies to Birdsong. We ran the survey during June and July 2024. The Breeze employee assistance package was available to staff during 2023/24, offering a range of benefits including a confidential helpline.

We greatly value our volunteer workforce as an integral part of the Hospice and have 749 registered volunteers supporting all teams. A staggering 76% of volunteers (573) work in our retail operation and provide the backbone to this vital source of income generation. In 2023/24 we undertook a volunteer survey. The feedback was very positive, with respondents reporting that they feel welcomed, valued and respected by the Hospice.

Trustees’ Report 2023/24

15

Patient and Family Experience of Care

During 2023/24 the Hospice delivered a robust programme of engagement with all those who use our services. We use the information to understand what is important to patients and families and continuously improve our services. It also enables us to recognise and celebrate outstanding care and many of the comments name individual members of staff or whole teams. Across the year we collected feedback in different ways, including the Bereaved Carers Survey and surveys on specific service areas.

The questions in each survey vary. Over 200 positive comments were submitted as part of this feedback programme with consistent themes:

----- Start of picture text -----
Outstanding Care Time taken to care
Grateful to be here
Compassionate staff
Care for both patient and family
----- End of picture text -----

Feedback from patients and families is also given directly to Hospice staff and posted on the Hospice website. All feedback is reviewed by the relevant Head of Department, so that they appreciate the extensive body of supportive comments, understand what matters to people, identify any recommendation for change and can share across the services. The governance and reporting mechanism for all feedback is overseen by the Chief Nurse.

Detailed quarterly reports are presented to the Hospice Involve Group, Quality Assurance Group and the Clinical and Academic Governance Committee. In 2024/25 the Hospice will be using a new platform, ‘I Want Great Care’, to analyse and report all our feedback. The platform takes feedback in electronic or paper format and provides access to questionnaires in easy-read and translated formats.

Trustees’ Report 2023/24

16

Throughout the year we conducted the Bereaved Carers Survey for all families of patients who died on the In-Patient Unit (IPU).

Across the year St Gemma’s received 154 responses, accounting for 41% of all IPU deaths, which is a significant increase on the previous year. Key findings include:

----- Start of picture text -----
Although a
Everyone who responded
smaller number
Over of carers
100%
responded to
across the year was
99% the question 97%
satisfied or highly
were satisfied on spiritual/ of respondents
satisfied with all
with their pain emotional care, felt their
key aspects of care,
and other relative died in
including ‘personal care’,
symptom 96% the right place.
their ‘ability to raise
management. were satisfied
questions’, ‘privacy
with their
& dignity’ and the
‘professionalism of staff’. relative’s care.
----- End of picture text -----

We also undertake surveys to generate feedback about individual services. In 2023/24 service specific surveys were undertaken in Community services for the Clinical Nurse Specialist (CNS) team and for Outpatients, and in Bereavement Services, both adult and young people’s, generating responses from 137 service users in total.

A small number of questions were asked across all surveys, with consistent responses:

----- Start of picture text -----
100%
100%
of respondents felt ‘listened to’
felt able to ask questions.
and ‘respected’.
100%
All those who responded to the Community CNS survey were confident in the
nurse’s ability and were happy to see them again. This quote is typical of the many
comments made:
“I would not have survived the last 9 months caring for
my relative who has complex problems, without
St Gemma’s nursing service and the wonderful support.”
----- End of picture text -----

The Outpatient survey formed part of the evaluation of the services following their re-introduction after the pandemic. It is clear from the comments that the service is valued and an integral part of St Gemma’s overall service offer:

Yes, it’s a place to come where I feel safe and meet friends. The nurses are amazing and I can’t fault them, they can’t do enough for me.

17

Trustees’ Report 2023/24

Across the Bereavement Services, 100% of respondents said they would recommend the service to others.

The Bereavement Surveys are sent out to clients when they are discharged and across both 2022/23 and 2023/24 the response rates for both adult and young people’s surveys have been low. The service leads are currently reviewing how feedback is generated and if there are other ways to understand the impact of the services.

Securing our Financial Future

During 2023/24 we received core grant income from NHS Leeds of £4.31m (2022/23: £4.28m). This represented an increase of £34k, reflecting a marginal cost of living increase. We are working with

the West Yorkshire Hospice Collaborative and the West Yorkshire Integrated Care Board (ICB) to secure increased NHS funding for the future. As a leadership team we are fully engaged with the new structures, including the ICB and the Leeds End of Life Board, responding to changing reporting requirements and presenting our case for funding, outlining the positive impact and outcomes of our services.

The remainder of our income in 2023/24 was generated through the local community. Although COVID restrictions were lifted, there was still some concern amongst the public early in the year and it is clear that the landscape for fundraising and mass participation events has changed. As businesses continue to operate flexible working practices, they have less ability to raise charitable funds through on-site office activity, which in turn has reduced corporate sector income.

Despite these challenges, we were able to generate £14m in total during the financial year, including our NHS income. The results were driven by a number of factors, including the excellent services delivered by our clinical and support teams, increased activity and focus on the income generation team, investments made in specific areas and a record-breaking year in retail.

All of this was underpinned by the sustained and generous support of donors and communities in Leeds. We are extremely grateful to all those who make donations, take part in fundraising events, leave a gift in their Will, donate their time through volunteering, or help the Hospice in any way. It would simply not be possible to raise the money needed for patient and family care without this support. The strength of our income generation activities comes in part from the breadth of our portfolio. During the year we continued to invest and capitalise on opportunities for income and plan for future financial sustainability.

We are ever conscious of the external environment including the cost of living crisis, other socioeconomic challenges, changing demographics and the health needs of the population. We regularly review all our services to ensure that we are responsive to those changing needs, operating as efficiently as possible and spending wisely in delivering our care.

Developing the Academic Unit of Palliative Care

The Academic Unit of Palliative Care (AUPC) has continued to grow, develop and consolidate its position as a centre of excellence for improving care of those approaching the end of life through integrated research, teaching and translating evidence into clinical practice.

18 »

Trustees’ Report 2023/24

The Senior Academic Leadership Team developed and is now implementing a refreshed AUPC strategy for the period 2024-2028. This strategy dovetails with the overall Hospice Strategy 2018-28 and its pillars of Impact, Connect and Extend.

The 15 strong research team, based at the University of Leeds, leads a large portfolio of research that aims to improve the assessment and management of pain, increase access to palliative care, improve identification and management of symptoms towards the end of life and reduce inequalities in palliative care delivery locally and globally.

The AUPC at the University of Leeds has secured funding along with Kings College London and the Wolfson Centre (Hull York Medical School) to establish the first UK Policy Research Unit for Palliative and End of Life Care.

Sarah Mitchell (Associate Professor) has been appointed National Clinical Director for Palliative and End of Life Care for a three year term. She has also secured funding to establish a Leeds Deepend Research Alliance. The Deepend Alliance will build research capacity and capability with GP surgeries providing care for under-served communities with multiple health needs throughout Leeds.

In 2023/24 we appointed a Research Practitioner, funded by the National Institute for Health Research, to further embed and develop our research portfolio in the Hospice.

The Education team has continued to deliver a comprehensive programme of high-quality education and has trained a total of 1,013 external health and social care professionals as well as St Gemma’s staff. This has been a period of developing and embedding new programmes and reviewing and updating existing programmes. It has also been a time to review the learning and teaching objectives in line with the overall AUPC Strategy, with some exciting new developments in the future particularly in expanding the communication skills training.

We continue to deliver clinical placements and have seen an increase in the demand for elective placements from across the country and internationally. We hosted 174 people on placement compared to 128 in the previous year.

The Evidence Based Practice group promotes a culture of effective decision-making, based on the best available evidence and clinical debate. The group has overseen a broad range of clinical and national audits this year and updated clinical guidance against emerging evidence. The audits include Equitable Care for All Ethnicities, Pressure Ulcers and Care after Death. Each audit generates a report highlighting good practice, future learning needs and recommendations.

The monthly community Journal Club encourages St Gemma’s staff to scrutinise evidence, share knowledge and continually challenge practice. There is a bi-monthly Book Club for all Hospice staff, with each book chosen to explore topics of relevance to the Hospice, such as bereavement, family dynamics and emotional wellbeing, to prompt reflection and fresh insights.

The team has replaced ‘Practice Enquiry’ with a new monthly meeting for all Hospice staff called ‘Lunch and Learn’, where each month a different department discusses a topic and how evidence in this area is used to improve quality and standards. This is open to all clinical and non-clinical staff with a view to ensuring best practice is being used across all departments at St Gemma’s Hospice.

Ensuring Equality, Diversity and Inclusion

St Gemma’s depends on engagement with its workforce and community to deliver high quality palliative and end of life care that meets the needs of that community and to build a strong sustainable future.

The Hospice relies on community support. We are proactive in planning, evaluating services and engaging with the city. The Hospice’s Involve Group promotes diversity, inclusivity and engagement.

19

Trustees’ Report 2023/24

Focusing on the five themes of workforce, service user experience, community engagement and accessibility, governance and communications, some of the achievements of Involve in 2023/24 were:

St Gemma’s has commenced an engagement project with our local Pakistani communities. In its early stages, the project aims to work with local groups to understand the need for and enhance referrals into Hospice services. As part of this work, we brought together local groups and leaders for a Community Iftar, to break fast during Ramadan in March 2024.

We continued work on the Dying Well in Seacroft project, with input from local people and from health and care providers, seeking to understand how to improve care in a particular geographic location with high levels of deprivation.

Our Inclusion service, improving care for homeless and vulnerably housed people at the end of life, is entirely dependent on hearing the voices of this group of people, and, with other homelessness services, building care around their needs. Our Nurse Consultant Lead for the service is working with the West Yorkshire ICB to provide advice and support to other palliative care providers in the region.

Driving Sustainability

We are committed to being environmentally sustainable and continue to develop plans that have a positive impact on the environment and our local community.

During 2023/24, we completed an independent energy assessment of our buildings, providing a framework and supporting action plan to reduce our carbon emissions. These energy saving initiatives support the government regulated Energy Savings Opportunity Scheme (ESOS) assessments that will be undertaken during 2024/25.

We continue with our programme to replace older, energy inefficient lighting (e.g. fluorescent lights) with light emitting diode (LED) lights. We have now upgraded 80% of the lights on our main site and will complete this project in 2024/25. The lighting in many of our shops has also been upgraded during the year.

In June 2023 we completed The Cabin, a unique and sustainable structure that was influenced by our young people. This Cabin offers a confidential safe space and social area for one on one and group activities. The Cabin was awarded the best healthcare project at the Structural Timber Awards in October 2023.

Our gardens continue to create a unique haven for patients and their visitors and gain many prestigious awards. In 2023 we were awarded Yorkshire in Bloom Gold and joint best in category, reflecting the diversity of our gardens. We have re-landscaped parts of the garden, introduced wildflower meadows and created new habitats to encourage wildlife and increase the ecological and biodiversity of the site.

20

Trustees’ Report 2023/24

Looking Ahead

St Gemma’s Hospice Strategy 2018 to 2028 provides a framework for the long-term development of St Gemma’s services under three pillars of Impact, Connect and Extend. These pillars are supported by our foundation priorities which focus on clarity of scope, quality of services and sustainability of our Hospice. The Hospice Strategy is consistent with the palliative care strategy for Leeds and West Yorkshire and considers the needs and wishes of patients, families and staff, likely future changes in need as well as national guidance and best practice.

Strategic Priorities

Our priorities include improvements to services, systems and infrastructure. To ensure adequate time to implement, embed and evaluate these significant pieces of work, our business plans now span at least two years. We have revised the original business plan with some new and some ongoing pieces of work. Other projects have been completed.

Examples of projects and programmes on the business plan 2024 to 2026 are:

A robust and structured project management methodology supports this work, leading to greater consistency, transparency, and an increased focus on project outcomes and prioritisation.

Clinical Quality Improvement Priorities

For 2024/25 we have agreed the following five improvement priorities, as outlined in our recently published Quality Account 2023/24:

The team will report on progress against these priorities on a quarterly basis to the Clinical and Academic Governance Committee.

Hospice Workforce and Culture

Our workforce remains St Gemma’s most important asset. We will continue to create a culture where wellbeing is a high priority, where staff and volunteers thrive and where there are opportunities for training and development. Our activities continue to be driven by staff, including our Wellbeing Champions. In 2024/25 we will review our staff engagement group to make sure it meets the needs of the Hospice team.

We will be offering staff a new employee assistance package in 2024/25, provided by Health Assured. We will consider carefully the findings of our 2024 staff survey to identify areas for potential improvement to staff experiences of St Gemma’s.

Investment is planned in 2024/25 to secure the future of volunteering at St Gemma’s, aiming to create more opportunities to recruit and retain volunteers.

21

Trustees’ Report 2023/24

Financial Review

Year on Year Income Review

The Financial Statements comply with the Charities Act 2011, the Companies Act 2006 and the Charities Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard (FRS 102).

The statement of financial activities shows net expenditure for the year of £834,639 (2023: net income £1,540,417) prior to any gains or losses on investments. Total income for the year was £13,986,626 (2023: £15,059,298) representing a decrease of £1,072,672 (7.1%) as legacies returned to an average level. Strong trading in our shops including online sales (£264,720 higher than 2023) and investment income returns (£118,798 more than 2023) contribute to our highest income generation, excluding legacies, on record.

Despite the fear of a recession the UK economy grew in the last quarter of 2023/24 financial year faster than the end of 2021 and the end of COVID positively impacted our financial results. However, a challenge remained with rising wage inflation, significant operational cost increases (e.g. utilities) and cost of living crisis impacting our income generating activities which influences our longer-term financial sustainability. We continue to be in a position of strength with adequate levels of general reserves to support our response to this unique financial challenge. This is considered in our review of reserve utilisation, principal risks and going concern (pages 25-29).

West Yorkshire Integrated Care Board (ICB) grant of £4,313,568 (2023: £4,279,346) represents an increase of £34,222 (0.8%). This increase reflects an inflationary uplift minus an efficiency savings reduction.

Shop income of £4,360,987 (2023: £4,096,267) which includes income from the subsidiary company, represents an increase of 6.5% across our 25 charity shops. Our investment in new retail units and continuing strong demand in existing shops continue to drive income growth. The net income from shops was £1,087,821 (2023: £1,336,023) representing a decrease of £248,202 (18.6%).

Income from donations, trust grants, lottery and fundraising events was £2,590,601 (2023: £2,517,202) an increase of £73,399 (2.9%). This reflects an increase in Fundraising £104,270 (17.2%), Lottery £51,286 (14.5%) and Trust Grants of £2,936 (2.4%) offset by a reduction in Donations of £85,093 (5.9%). This reduction is partly due to lower general donations being assigned to other categories due to improved internal processes and in funeral donations reducing, possibly in response to the cost of living crisis.

Total expenditure of £14,821,265 (2023: £13,518,881) increased by £1,302,384 which represents an increase of 9.6%. This increase is due to the annual pay award (including one-off payments) and additional costs associated with investment in our retail and income generation activities. We continue to control expenditure and drive improvements to support our long-term financial plan.

The investment portfolio generated a gain of £457,357 (2023: loss £465,381). The investment portfolio is managed for long-term growth in both its capital value and the level of income it can generate. For the year to March 2024 the portfolio’s total return was 4.15% (2023: -4.5%) compared to a benchmark of 7.51% (2023: -1.5%).

The 12 months to 31 March 2024 saw strong returns from global equity markets as investors reacted positively to inflation continuing to fall and the prospect of impending interest rate cuts. However, much of the equity market return was dominated by a small number of large technology companies that benefitted from investor enthusiasm on artificial intelligence. More diversified investors consequently struggled to keep pace with the market return given this narrow market leadership. Other asset class returns were more muted for the period with bond markets and

Trustees’ Report 2023/24

22

infrastructure assets continuing to struggle in the face of high interest rates but Gold delivered a strong return as an asset class, helped by central bank buying and increased geo-political risks.

Total Return(%) One Year 3 Years 5 Years
Portfolio 10.0 11.6 30
Benchmark 15.3 25.4 37.6
CPI +3% Objective 6.2 32.2 43.3
ARC Charity Steady
Growth*		 9.4 11.5 27.4

*ARC Steady Growth Charity Index represents charity portfolios that exhibit between 60%-80% of the volatility of the UK equity market, which is comparable with this portfolio

At year end the investment portfolio was valued at £6,674,068 (2023: £6,248,717) with investment management fees of £32,597 (2023: £31,390). Overall investment income was £313,834 (2023: £195,036) with the investment portfolio contributing dividend payments of £157,967 (2023: £171,673). Companies continued to retain funds rather than making dividend distributions to shareholders and this trend is expected to continue 2024/25. We generated £155,867 (2023: £23,363) from bank interest on approved short and medium-term deposits. We have seen a £132,504 increase in bank interest earned through the proactive investment of our surplus cash balances in higher rate deposit accounts.

The investment portfolio is managed by external fund managers (Rathbones) and performance is monitored by the Finance and Business Committee with an independent review every 3 years. All investment decisions are made in accordance with the approved investment policy. This policy sets out the investment powers, objectives, risk profile, the types of investment and the benchmarks used for performance monitoring. A range of benchmarks are used to assess investment performance including a bespoke benchmark, agreed with the external fund managers, that reflects the Trustees’ wish for good returns balanced with the need to manage risk. At the year end the portfolio was invested in a mixture of equities (77%), fixed interest (10%), property (3%), cash deposits (1%) and alternative assets (9%).

23

Trustees’ Report 2023/24

Income Chart Comparison 2022/23 - 2023/24

----- Start of picture text -----
£4,500k £4,361k £4,314k
2022/23 2023/24
£4,000k
£3,500k
£3,000k
£2,500k
£2,000k £1,797k
£1,500k
£1,351k
£1,133k
£1,000k
£711k
£500k
£165k £124k
£31k £0k
£0k
Shops NHS Leeds Legacies Donations Other Fundraising LPCN Trusts Controlled NHS
Grant Income Drugs Other
----- End of picture text -----

St Gemma’s Hospice Services Ltd (trading subsidiary) continued to sell bought in goods and receive a lottery licence fee. During 2023/24 there was limited room hire income of £930. The company made a net surplus of £3,127 (2023: £10,579) in the year which will be transferred to the Hospice under Gift Aid.

----- Start of picture text -----
Other Income
8.1% - £1,133k
Shops Donations
31.2% - £4,361k 9.7% - £1,351k
Overall Income 2022-23
Overall Income 2023-24
Legacies
12.8% - £1,797k
£15.1m
£13.99m
Fundraising Trusts
5.1% - £711k
0.9% - £124k
Controlled Drugs
0.2% - £31k
LPCN
1.2% - £165k
West Yorkshire ICB Grant
30.8% - £4,314k
----- End of picture text -----

Trustees’ Report 2023/24

24

Reserves

The Board of Trustees operates a risk based approach to determine the levels of reserves needed to cover key financial risks and support the long-term strategy and five-year plan. The Board has agreed a minimum general reserve fund of £3.7m as adequate to cover those assessed financial risks. This includes a £3.3m provision to support costs and liabilities associated with reorganising the Hospice in response to a significant reduction in income. This minimum reserve level is considered by the Board alongside the five-year financial plan and capital investment requirements on an annual basis.

The general reserves are drawn from unrestricted funds, excluding funds designated for future expenditure and those funds already invested in fixed assets. The unrestricted general reserve is currently £8,806,124 (2023: £11,215,950). The decrease of £2,409,826 is due to the creation of a Buildings Upgrade Reserve (£2,000,000) and AUPC Strategy Reserve (£500,000) in Designated Reserves to support delivery of the Hospice Strategy.

Total designated reserves 31 March 2024 were £5,921,053 (2023: £3,889,375) of which £2,551,764 (2023: £2,556,917) has been invested in fixed assets. The designated reserves, excluding fixed assets, are £3,369,289 (2023: £1,332,458). We hold appropriate designated reserves to support the delivery of St Gemma’s Hospice Strategy 2018-2028. These reserves can be designated, re-designated or released at the discretion of the Board. Current designated reserves include:

See notes 16 and 17 of the financial statements for further information on reserve utilisation.

Fixed Assets and Investments

The movements in fixed assets and investments during the period are set out in notes 10 and 11 to the financial statements. The Board of Trustees has the power to invest the charity’s money in the manner they consider most beneficial for the purposes of St Gemma’s Hospice.

25

Trustees’ Report 2023/24

Structure, Governance and Management

St Gemma’s Hospice was founded in 1978 by the Sisters of the Cross and Passion who retain ultimate control of the company. The members of the company all belong to this congregation. The Hospice is a charitable company limited by guarantee and a registered charity.

The Board is supported by three Committees that meet on a quarterly basis:

Clinical and Academic Governance Committee

This Committee has delegated responsibility for oversight of clinical and academic governance, strategy, and delivery.

The directors of the company are also charity Trustees for the purposes of charity law and are known as the Board of Trustees. Trustee Indemnity Insurance is provided for the benefit of the Trustees.

Corporate Governance Committee

This Committee has delegated responsibility for oversight of Hospice corporate governance arrangements, risk management, culture (including equality, diversity, and inclusion) and compliance with the Charity Governance Code. The Committee is also responsible for Board succession planning, and recruitment of Trustees and the Hospice Leadership Team.

The Trustees have complied with the duty (set out in section 4 of the Charities Act 2011) to have due regard to public benefit guidance published by the Charity Commission. This report indicates how our activities have delivered public benefit.

Finance and Business Committee

This Committee has delegated responsibility for oversight of the financial strategy, annual budget, income generation and longer-term financial planning. The Committee is also responsible for overseeing the investment of Hospice funds and recommending the appointment of an investment manager to the Board.

The Board of Trustees includes one representative of the Sisters of the Cross and Passion with a deputy if required. The remaining members of the Board of Trustees have been recruited for their experience and skills in relevant areas including medicine and nursing, finance, legal and commerce. The Trustees who served during the year are set out on page 5.

The Board of Trustees is responsible for overseeing the Hospice’s strategy and performance. It is chaired by Philomena Corrigan. The Board powers are detailed in the Articles of Association.

Full meetings of the Board of Trustees are held at least four times a year to review the performance of the Hospice and to agree any major changes to the strategy or financial plans. These meetings are supported by two focused strategy and development sessions a year.

During the year, the Hospice had more than the maximum number of Trustees as recommended in the Charity Governance Code. The total number of Trustees serving during the year was in accordance with the governing document. The Board values the continued support and wise counsel provided by the Sisters through this Constitutional arrangement.

Trustees’ Report 2023/24

26

Scheme of Delegation

The Board has approved a scheme of delegation under which the majority of operational management and decision making is delegated to the Chief Executive. The Chief Executive has a key role in the management and monitoring of service delivery, patient satisfaction, financial performance, the assessment and control of risk, and the prioritisation and allocation of resources.

The Hospice Leadership Team (HLT) reports to the Board and its Committees, leading on strategy development, overseeing the provision of Hospice services, and managing risk. The HLT is supported by Heads of Department, closely managing day to day service provision.

The HLT comprises the Chief Executive, Kerry Jackson; Chief Nurse, Heather McClelland; Chief Medical Officer and Consultant in Palliative Care, Dr Mike Stockton; Director of Income Generation, Kate Goldring; Chief Operating Officer, Jason Kirk. The Chief Executive and HLT are not members of the Board and have no beneficial interest in the company.

Senior Staff Pay

The pay of the senior staff is reviewed by the Board of Trustees, through its Remuneration Committee. The levels of remuneration paid to senior employees are carefully considered compared to other roles in the market and are benchmarked, as required, against other local hospices and national charities. The Hospice directly employs four medical consultants on NHS equivalent contracts, in line with national agreements.

The levels paid are those necessary to ensure a well-run, effective organisation in line with regulatory requirements. Competitive salaries help the Hospice to attract, recruit and retain the best possible calibre of staff, in a competitive environment.

Risk Management and Principal Risks

The Board has overall responsibility for establishing and maintaining the whole system of internal control and the management of risk, including reviewing the effectiveness of internal controls. The Board has adopted a risk based approach to establishing and maintaining internal controls, which are embedded within day to day management and governance processes.

The Board of Trustees assesses and reviews the management of the major risks to which the charity and its subsidiary company, St Gemma’s Hospice Services Limited, are exposed, including financial, clinical, and business risks. The risk register is developed by the HLT and is scrutinised by the relevant Committees and Board on a quarterly basis.

27

Trustees’ Report 2023/24

The key risks facing the Hospice are:

Information Governance

We comply with the Charity Governance Code, review Information Commissioner’s Office (ICO) guidance and submit the NHS Data Security and Protection Toolkit (DSPT) which enables us to measure and publish performance against the National Data Guardian’s ten data security standards.

Trustees Fundraising Statement

Income Generation at St Gemma’s is conducted by a team of fundraisers and retail staff directly employed by the charity and led by the Director of Income Generation. The Hospice also generates Lottery income through an external partner (Local Hospice Lottery Limited) and their team of directly employed lottery fundraisers. There have been no failures to comply with the standards set by these organisations and St Gemma’s is fully committed to the delivery of high quality, engaging and compliant fundraising activity.

The Trustees of the Hospice monitor the activities of the Income Generation team via quarterly meetings of the Finance and Business Committee, supported by regular meetings of the Income Review Group. The Chair of the Committee also meets monthly with the Chief Operating Officer and Director of Income Generation. Policies to protect vulnerable individuals are in place and all fundraisers are aware of their responsibilities in this area. During 2023/24 there were six complaints (2022/23: Two) relating to the Hospice’s fundraising activities and no complaints (2022/23: None) relating to the chain of charity shops. The complaints highlighted opportunities for process improvements which are being implemented.

Trustees Responsibility Statement

The Trustees (who are also directors of St Gemma’s Hospice for the purposes of company law) are responsible for preparing the Trustees’ Annual Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law mandates Trustees to prepare financial statements annually that accurately

Trustees’ Report 2023/24

28

represent the financial status of the charitable company and group, including incoming resources, resource allocation, income, and expenditures. The Trustees must ensure these statements comply with legal requirements.

The Trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

In so far as the Trustees are aware:

The Trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Going Concern

As part of our annual financial planning arrangements, the Board approved budget plans for 2024/25 and a supporting five-year financial outlook in considering the sustainability of the Hospice. This included a review of cashflows, capital investment needs and minimum level of general reserves. We have recorded a deficit of £377.3k this financial year but retain a strong asset base and general reserves of £8.8m to support the Hospice and ensure financial sustainability. Our cash flow forecasts and supporting management accounts all project sufficient liquid balance of funds to support sustainability.

The Board is satisfied that the charity has a reasonable expectation of continuing in operational existence for the foreseeable future and so has continued to adopt the going concern basis in preparing the financial statements. This confirmation is given and should be interpreted in accordance with the provisions of s418 of the Companies Act 2006.

Auditor:

Saffery LLP have expressed their willingness to continue as auditor for the next financial year.

The Trustees’ Report, including the Strategic Report, was approved by the Board, and signed on its behalf by:

Philomena Corrigan

Chair of the Board of Trustees

----- Start of picture text -----
Date
17 October 2024.
----- End of picture text -----

----- Start of picture text -----
Signature
----- End of picture text -----

29

Trustees’ Report 2023/24

Independent Auditor’s Report to the Members of St Gemma’s Hospice

Opinion

We have audited the financial statements of St Gemma’s Hospice (the ‘parent charitable company’) and its subsidiary (the ‘group’) for the year ended 31 March 2024 which comprise the group statement of financial activities, the group and parent charitable company balance sheets, the group cash flow statement and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group or the parent charitable company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The trustees are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Trustees’ Report 2023/24

30

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information; we are required to report that fact. We have nothing to report in this regard.

Other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent charitable company and their environment obtained in the course of the audit, we have not identified material misstatements in the Trustees’ Annual Report and Strategic Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 require us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the Statement of Trustees’ Responsibilities set out on pages 28-29, the trustees (who are also the directors of the parent charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied

that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of the financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the group and the parent charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the group or the parent charitable company or to cease operations or have no realistic alternative but to do so.

31

Trustees’ Report 2023/24

Auditor’s responsibilities for the audit of the financial statements

We have been appointed as auditors under the Companies Act 2006 and report in accordance with regulations made under that Act.

Our objectives are to obtain reasonable assurance about whether the group and parent financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non- compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The specific procedures for this engagement and the extent to which these are capable of detecting irregularities, including fraud are detailed below.

Identifying and assessing risks related to irregularities: We assessed the susceptibility of the group and parent charitable company’s financial statements to material misstatement and how fraud might occur, including through discussions with the trustees, discussions within our audit team planning meeting, updating our record of internal controls and ensuring these controls operated as intended. We evaluated possible incentives and opportunities for fraudulent manipulation of the financial statements. We identified laws and regulations that are of significance in the context of the group and parent charitable company by discussions with trustees and updating our understanding of the sector in which the group and parent charitable company operate.

Laws and regulations of direct significance in the context of the group and parent charitable company include The Companies Act 2006 and guidance issued by the Charity Commission for England and Wales.

Further, the parent charitable company is subject to other laws and regulations where the consequences of non-compliance could have a material effect on amounts or disclosures in the financial statements; through a significant fine, litigation, prosecution or restrictions on the parent charitable company’s operations. We identified the most significant laws and regulations to be those issued by the Care Quality Commission (‘CQC’) covering the provision of health and social care in England.

Audit response to risks identified:

We considered the extent of compliance with these laws and regulations as part of our audit procedures on the related financial statement items including a review of financial statement disclosures. We reviewed the parent charitable company’s records of breaches of laws and regulations, minutes of meetings and correspondence with relevant authorities, including the CQC, to identify potential material misstatements arising. We discussed the parent charitable company’s policies and procedures for compliance with laws and regulations with members of management responsible for compliance.

During the planning meeting with the audit team, the engagement partner drew attention to the key areas which might involve non-

Trustees’ Report 2023/24

32

compliance with laws and regulations or fraud. We enquired of management whether they were aware of any instances of non-compliance with laws and regulations or knowledge of any actual, suspected or alleged fraud. We addressed the risk of fraud through management override of controls by testing the appropriateness of journal entries and identifying any significant transactions that were unusual or outside the normal course of business. We assessed whether judgements made in making accounting estimates gave rise to a possible indication of management bias. At the completion stage of the audit, the engagement partner’s review included ensuring that the team had approached their work with appropriate professional scepticism and thus the capacity to identify non-compliance with laws and regulations and fraud.

There are inherent limitations in the audit procedures described above and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities . This description forms part of our auditor’s report.

Use of our report

This report is made solely to the parent charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the parent charitable company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the parent charitable company and the parent charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Sally Appleton (Senior Statutory Auditor) for and on behalf of Saffery LLP

Chartered Accountants Statutory Auditors

Saffery LLP 10 Wellington Place Leeds LS1 4AP

Saffery LLP is eligible to act as an auditor in terms of section 1212 of the Companies Act 2006

----- Start of picture text -----
Date
31 October 2024.
{
Signature
----- End of picture text -----

33

Trustees’ Report 2023/24

Consolidated statement of financial activities (Including consolidated income and expenditure account) For the year ended 31 March 2024

----- Start of picture text -----
Unrestricted Designated Restricted Total Total
Income From: Notes Funds Funds Funds Funds Funds
2024 £ 2024 £ 2024 £ 2024 £ 2023 £
Donations, legacies, grants 2 3,164,427 - 108,131 3,272,558 4,666,842
and trusts
Other trading activities: 3
Sale of donated goods 4,309,544 - - 4,309,544 4,050,961
Fundraising 710,987 - - 710,987 606,717
Lottery 399,035 - - 399,035 348,911
Commercial trading 57,374 - - 57,374 49,953
5,476,940 - - 5,476,940 5,056,542
Charitable activities -
Provision of
Hospice Services:
Grant Income from WYICB 4 4,313,568 - - 4,313,568 4,279,346
Additional WY ICB income - - - - 272,452
LPCN income 165,017 - - 165,017 182,499
Controlled drugs income 30,950 - - 30,950 66,788
Other grants - - - - 27,535
Education and research 159,579 - - 159,579 146,322
Bistro 83,518 - - 83,518 71,912
Other 170,662 - - 170,662 94,024
4,923,294 - - 4,923,294 5,140,878
Investments 5 313,834 - - 313,834 195,036
Total income 13,878,495 - 108,131 13,986,626 15,059,298
Expenditure On:
Raising funds
Cost of selling donated goods 3,138,629 80,290 - 3,218,919 2,720,870
Costs of raising income from
donations, legacies, trusts and 1,646,613 51,454 - 1,698,067 1,598,550
fundraising
Investment management fees 32,597 - - 32,597 31,390
Commercial trading operations 54,247 - - 54,247 39,374
4,872,086 131,744 - 5,003,830 4,390,184
Charitable activities - Provision
9,104,638 630,445 82,352 9,817,435 9,128,697
of Hospice Services
Total expenditure 6 13,976,724 762,189 82,352 14,821,265 13,518,881
----- End of picture text -----

34

Trustees’ Report 2023/24

Notes Unrestricted
Funds
2024 £		 Designated
Funds
2024 £		 Restricted
Funds
2024 £		 Total
Funds
2024 £		 Total
Funds
2023 £
Net income/(expenditure)
before investment (losses)/
gains		 8 (98,229) (762,189) 25,779 (834,639) 1,540,417
Net (losses)/gains on
investments		 11 457,357 - - 457,357 (465,381)
Net income/(expenditure) 359,128 (762,189) 25,779 (377,282) 1,075,036
Transfer between funds 16/17 (2,768,954) 2,793,867 (24,913) - -
Net movement in funds (2,409,826) 2,031,678 866 (377,282) 1,075,036
Reconciliation Of Funds:
Total funds brought forward 11,215,950 3,889,375 133,677 15,239,002 14,163,966
Net movement in funds for the
year		 (2,409,826) 2,031,678 866 (377,282) 1,075,036
Total funds carried forward 16/17 8,806,124 5,921,053 134,543 14,861,720 15,239,002

There were no other recognised gains or losses other than those listed above and the net income for the year.

All income and expenditure derive from continuing activities.

See note 15 for comparative Consolidated Statement of Financial Activities analysed by funds.

The accounting policies and notes on pages 38 to 55 form part of these accounts.

35

Trustees’ Report 2023/24

Balance Sheets As at 31 March 2024

----- Start of picture text -----
Notes Group Charity
Fixed Assets
2024 £ 2023 £ 2024 £ 2023 £
Tangible assets 10 2,551,764 2,556,917 2,551,764 2,556,917
Investments 11 6,674,068 6,248,717 6,674,070 6,248,719
9,225,832 8,805,634 9,225,834 8,805,636
Current Assets
Stocks 10,941 14,270 - -
Debtors 12 708,580 2,211,320 705,118 2,225,350
Current asset investments 3,500,000 2,531,416 3,500,000 2,531,416
Cash at bank and in hand 2,591,404 3,906,699 2,588,505 3,887,743
6,810,925 8,663,705 6,793,623 8,644,509
Creditors - amounts falling due within one
13 (1,175,037) (2,230,337) (1,157,737) (2,211,143)
year
Net current assets 5,635,888 6,433,368 5,635,886 6,433,366
Net assets 14,861,720 15,239,002 14,861,720 15,239,002
Represented by funds
Designated funds 16 5,921,053 3,889,375 5,921,053 3,889,375
General fund 16 8,806,124 11,215,950 8,806,124 11,215,950
Restricted funds 17 134,543 133,677 134,543 133,677
Total Funds 14,861,720 15,239,002 14,861,720 15,239,002
----- End of picture text -----

The financial statements were approved and authorised for issue by the Board of Trustees and signed on its behalf by:

----- Start of picture text -----
Date
17 October 2024.
Signature
----- End of picture text -----

Philomena Corrigan

Chair of the Board of Trustees

Company Number: 02773867

The notes on pages 38 to 55 form part of these accounts

Trustees’ Report 2023/24

36

Consolidated cash flow statement For year ended 31 March 2024

Notes Group
2024 £		 Group
2023 £
Net cash provided by operating activities
~~es~~		 19
~~es~~		 25,766
~~es~~		 2,030,216
~~es~~
Cash flows from investing activities
Dividends and interest received
~~a~~		 ~~a~~ 313,834
~~a~~		 195,036
~~a~~
Purchase of tangible fixed assets
~~a~~		 ~~a~~ (723,105)
~~a~~		 (644,866)
~~a~~
Loss on disposal of fixed assets
~~a~~		 ~~a~~ 4,788
~~a~~		 -
~~a~~
Purchase of investments
~~ee~~		 ~~ee~~ (5,059,731)
~~ee~~		 (1,583,281)
~~ee~~
Proceeds on sale of investments
~~a~~		 ~~a~~ 4,977,985
~~a~~		 1,609,777
~~a~~
Movement on cash held by Investment Managers
~~a~~		 ~~a~~ 113,752
~~a~~		 5,479
~~a~~
Net cash outflow/inflow from investing activities
~~a~~		 ~~a~~ (372,477)
~~a~~		 (417,855)
~~a~~
Change in cash and cash equivalents during the year
~~a~~		 ~~a~~ (346,711)
~~a~~		 1,612,361
~~a~~
Cash and cash equivalents at the beginning of the year
~~OO~~		 ~~OO~~ 6,438,115
~~OO~~		 4,825,754
~~OO~~
Total cash and cash equivalents at the end of the year
~~a~~		 ~~a~~ 6,091,404
~~a~~		 6,438,115
~~a~~
Reconciliation to balance sheet:
Cash at bank and in hand
~~a~~		 ~~a~~ 2,591,404
~~a~~		 3,906,699
~~a~~
Current asset investments
~~a~~		 ~~a~~ 3,500,000
~~a~~		 2,531,416
~~a~~
Balance at 31 March
~~a~~		 ~~a~~ 6,091,404
~~a~~		 6,438,115
~~a~~

The notes on pages 38 to 55 form part of these financial statements.

Trustees’ Report 2023/24

37

Statement of accounting policies For year ended 31 March 2024

Company and charitable status

St Gemma’s Hospice, meets the definition of a public benefit entity under FRS 102, is incorporated in England and Wales as a charitable company limited by guarantee not having a share capital. The Sisters of the Cross and Passion are the members of the company. Each member has undertaken to contribute to the assets in the event of winding up a sum not exceeding £1. The charity is a registered charity. The registered office is given on page 3.

Basis of accounting

The financial statements have been prepared under the historical cost convention with the exception of investments which have been included at market value. The financial statements have been prepared in accordance with Statement of Recommended Practice “Accounting and Reporting by Charities (SORP 2019)” applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102), effective 1 January 2019 and the Companies Act 2006.

The Company meets the definition of a qualifying entity under FRS 102 and has therefore taken advantage of the disclosure exemption available to it in respect of its separate financial statements in relation to presentation of a cash flow statement.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £1.

The principal accounting policies are set out below.

Basis of consolidation

The consolidated financial statements comprise St Gemma’s Hospice and its wholly owned subsidiary undertaking, St Gemma’s Hospice Services Limited. The summarised profit and loss account for the subsidiary is shown in note 1. The results of the subsidiary are consolidated on a line-by-line basis.

Preparation of the financial statements – going concern basis

The principal risks facing the charity are discussed in the Trustees’ report. Trustees have considered budget plans and a revised five-year financial outlook in considering the sustainability of the Hospice. The Trustees have also reviewed the cash position of the charity and cash forecasts at the date of signing the financial statements and are satisfied that the charity will be able to meet all of its financial commitments for at least twelve months from the date of signing.

As a consequence, the Trustees believe that the charity is well placed to manage its financial risks successfully. After making enquiries, the Trustees have a reasonable expectation that the charity has adequate reserves to continue in operational existence for the foreseeable future. Accordingly, the Trustees continue to adopt the going concern basis in preparing the financial statements.

Income

Income is recognised when the Group and Charity have entitlement to the funds, any performance conditions attached to the items of income have been met, it is probable that the income will be received, and the amount can be measured reliably.

Trustees’ Report 2023/24

38

Income received by way of donations, fundraising events, trading, legacies, and West Yorkshire Integrated Care Board (WY ICB) receipts are credited in the accounts when the charity is legally entitled to the income and the amount can be quantified with reasonable accuracy. These are shown gross before deductions of related expenses and net of VAT. Lottery income is from Local Hospice Lottery and the joint lottery with Sue Ryder Wheatfields Hospice and is included net after associated expenditure.

For legacies, entitlement is taken as the earlier of the date when all the following conditions are met: the charity is aware that probate has been granted, a copy of the will has been received to confirm entitlement, there is sufficient information to value the estate, a copy of the estate accounts are received and approved and the estimated value of the benefit exceeds £10,000. Where legacies have been notified to the charity, or the charity is aware of the granting of probate, and the criteria for income recognition have not been met, then the legacy is a treated as a contingent asset and disclosed where material.

Income tax recoverable on income received and bank interest received are included in these accounts on the accruals basis. Dividend income from investment funds is included when receivable and the amount can be measured reliably by the charity; this is normally upon notification of dividends paid or payable.

Deferred income includes amounts received in respect of grants received for work to be carried out in the next financial year.

Donated professional services and donated facilities are recognised as income when the charity has control over the item, any conditions associated with the donated item have been met, the receipt of economic benefit from the use by the charity of the item is probable and that economic benefit can be measured reliably.

On receipt, donated professional services and donated facilities are recognised on the basis of the value of the gift to the charity, which is the amount the charity would have been willing to pay to obtain services or facilities of equivalent economic benefit on the open market; a corresponding amount is then recognised in expenditure in the period of receipt. The full value of the freehold peppercorn rent is not valued due to the prohibitive cost of doing so. Income from goods donated for sale in the charity’s shops is recognised at point of sale. As a result of the high volume of low value donated goods received by the charity, the cost of recognising these items at their value on receipt would outweigh the benefit of recognising them in the financial statements.

All income arises in the United Kingdom. In accordance with Charities SORP FRS102), the value of volunteer time is not recognised in the financial statements. Please refer to the Trustees’ Annual Report for more information.

Expenditure

Expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required, and the amount of the obligation can be measured reliably. Expenditure is classified under the following activity headings.

Costs of raising funds include the costs incurred in generating voluntary income, fundraising trading costs, including the costs of running the charity shops, and investment management costs. Charitable expenditure has been analysed by activity, these costs enable the Hospice to meet its charitable aims and objectives.

Support costs cover functions that support the Hospice’s work but do not directly engage in charitable activities. This includes back-office, finance, personnel, payroll, and governance expenses. Governance costs are linked to the charity’s governance arrangements, including compliance, trustee meetings, and legal advice. These costs are divided between fundraising and charitable activities. The bases on which support costs have been allocated are set out in note 7.

Expenditure is included in the Statement of Financial Activities inclusive of any VAT which cannot be recovered.

Trustees’ Report 2023/24

39

Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Board of Trustees in the furtherance of the general objectives of the charity. Designated funds are amounts that have been put aside at the discretion of the Board of Trustees. Restricted funds are funds subject to specific conditions imposed by donors. Where restricted funds are received for the purchase of fixed assets then the funds are transferred to designated funds once the purchase has been made. See notes 16 and 17 for further information on funds and funds utilisation.

Tangible fixed assets

Tangible fixed assets are stated at cost, net of depreciation. Assets under construction are not depreciated until the asset is completed and brought into use or similar

Tangible fixed assets individually costing more than £1,000 are capitalised and included in the accounts at cost. Provision is made for depreciation on all tangible assets at rates calculated to write off the cost of each asset over its expected useful life as follows:

Improvements to leasehold property costs 5% per annum on a straight line basis
Fixtures and fttings 10% per annum on a straight line basis
Motor vehicles 25% per annum on reducing balance basis
Computer Equipment 25% per annum on a straight line basis

Investments

Listed investments are included in the financial statements at market value. Investment in subsidiary is recognised at cost. The Statement of Financial Activities includes the net gains and losses arising on revaluations and disposals throughout the year.

Stock

Stock of purchased goods is valued at the lower of cost and net realisable value. Items donated for resale are not included in the financial statements until they are sold.

Employee benefits

The Hospice operates two pension schemes. A defined benefit scheme with the National Health Service Superannuation Scheme is only available to staff who have previously contributed to the scheme. The administration of this scheme is dealt with by the National Health Service Pension agencies. In addition, there is a Group Personal Pension Scheme administered by Standard Life which is available to all other employees. Contributions to both Schemes are charged directly to the Statement of Financial Activities. Differences between contributions payable in the year and contributions actually paid are shown as either accruals or prepayments in the balance sheet.

Operating leases

Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Financial instruments

Financial assets and financial liabilities are recognised when the Group becomes a party to the contractual provisions of the instrument. All financial assets and liabilities are initially measured at transaction price (including transaction costs). The charity and group only have financial assets and financial liabilities of a kind that qualify as basic financial instruments. With the exception of fixed asset investments, basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

Trustees’ Report 2023/24

40

Current asset investments include short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

Cash at bank and cash in hand includes cash and short-term highly liquid investments with a short maturity held for working capital.

Taxation

The Hospice is a registered charity and as such is a charity within the meaning of schedule 6 of the Finance Act 2010. Accordingly, the Hospice is potentially entitled to tax exemption under part 11 of the Corporation Tax Act 2010 or section 256 of the Taxation of Chargeable Gains Act 1992 in respect of income and gains arising. Given this, no tax charge arises on the charity.

The trading subsidiary is liable to corporation tax on its taxable profits. Current tax, including UK corporation tax and foreign tax, is provided at amounts expected to be paid (or recovered) using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Critical accounting judgements and key sources of estimation uncertainty

In the application of the Group’s accounting policies described above, the Trustees are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

Legacies

Legacies are recognised as income when probate has been granted, the charity has established its entitlement to the funds and sufficient information is available to allow the measure of entitlement, and it is probable that funds are receivable.

Trustees’ Report 2023/24

41

Notes to the Group Financial Statements For year ended 31 March 2024

1. NET INCOME FROM TRADING ACTIVITIES OF SUBSIDIARY

The charity has a wholly owned subsidiary, St Gemma’s Hospice Services Limited which is incorporated in the UK and registered in England and Wales No 03739423. The company undertakes trading activities including the sale of bought in goods and the provision of room hire within the St Gemma’s Academic Unit of Palliative Care. A summary of its trading results for the period is shown below. The company donates its taxable profit to St Gemma’s Hospice under Gift Aid. Audited accounts will be filed with the Registrar of Companies.

----- Start of picture text -----
Profit and Loss Account 2024 £ 2023 £
Turnover 57,374 49,953
Cost of Sales (26,173) (17,281)
Gross Profit 31,201 32,672
Administrative expenses (2,624) (846)
Management charge (25,450) (21,247)
Operating profit 3,127 10,579
Charitable donation to St Gemma’s Hospice (3,127) (10,579)
Retained in subsidiary - -
Aggregate Capital and reserves 2 2
----- End of picture text -----

2. INCOME FROM DONATIONS, LEGACIES AND TRUSTS

----- Start of picture text -----
Unrestricted Funds Restricted Funds Total
2024 £ 2024 £ 2024 £
Donations 1,313,581 37,650 1,351,231
-
Legacies 1,796,980 1,796,980
Grants and Trusts 53,866 70,481 124,347
3,164,427 108,131 3,272,558
Unrestricted Funds Restricted Funds Total
2023 Comparative
2023 £ 2023 £ 2023 £
Donations 1,302,475 133,849 1,436,324
Legacies 3,104,107 5,000 3,109,107
Grants and Trusts 11,040 110,371 121,411
4,417,622 249,220 4,666,842
----- End of picture text -----

At 31 March 2024 there were legacies totalling £1,019,172 (2023: £1,410,319) that had been notified as receivable to the charity but have not been included in the financial statements as they did not comply with the recognition requirements of the accounting policy. A legacy of £180,000 has not been recognised within the accounts as it did not comply with the full recognition requirements for the asset.

Included in donations is gift aid received or receivable of £173,023 (2023: £174,832).

Trustees’ Report 2023/24

42

3. INCOME FROM FROM OTHER TRADING ACTIVITIES

----- Start of picture text -----
2024 £ 2023 £
Sale of donated goods 4,309,544 4,050,961
Fundraising 710,987 606,717
Lottery 399,035 348,911
Income from wholly owned subsidiary:
Room hire 930 808
Sale of purchased goods 51,443 45,306
Lottery License fee 5,001 3,839
5,476,940 5,056,542
----- End of picture text -----

The sales of donated and purchased goods in 2024 includes donations under retail gift aid of £784,734 (2023: £730,089) and the associated gift aid of £193,829 (2023: £183,332). St Gemma’s Hospice had 25 shops at the year end (2023: 24).

4. INCOME FROM CHARITABLE ACTIVITIES

----- Start of picture text -----
Unrestricted Funds Restricted Funds Total
2024 £ 2024 £ 2024 £
Provision of hospice services
Grant income from WY ICB 4,313,568 - 4,313,568
LPCN income 165,017 - 165,017
-
Controlled drugs income 30,950 30,950
Education and research 159,579 - 159,579
Bistro 83,518 - 83,518
Other 170,662 - 170,662
-
4,923,294 4,923,294
Unrestricted Funds Restricted Funds Total
2023 Comparatives
2023 £ 2023 £ 2023 £
Provision of hospice services
Grant income from WY ICB 4,279,346 - 4,279,346
Additional WY ICB Income 272,452 - 272,452
LPCN income 182,499 - 182,499
-
Controlled drugs income 66,788 66,788
-
Covid 19 grant income from NHSE 27,535 27,535
Education and research 146,322 - 146,322
Bistro 71,912 - 71,912
Other 94,024 - 94,024
5,113,343 27,535 5,140,878
----- End of picture text -----

5. INVESTMENT INCOME

All investment income for 2024 and 2023 was unrestricted.

----- Start of picture text -----
2024 £ 2023 £
Listed securities 157,967 171,673
Bank and other interest 155,867 23,363
Total 313,834 195,036
----- End of picture text -----

Trustees’ Report 2023/24

43

6. ANALYSIS OF EXPENDITURE

----- Start of picture text -----
Direct Costs Support Costs Total
Expenditure on raising funds
2024 £ 2024 £ 2024 £
Costs of selling donated goods 2,931,437 287,482 3,218,919
Cost of raising income from donations,
1,431,737 266,330 1,698,067
legacies, trusts and fundraising
-
Investment management fees 32,597 32,597
Cost of wholly owned subsidiary:
-
Purchased goods 54,247 54,247
4,450,018 553,812 5,003,830
Expenditure on charitable activities
Provision of hospice services
In-Patient Care 5,595,038 657,423 6,252,461
Community Care 1,731,364 160,752 1,892,116
Out-Patients 515,629 109,988 625,617
Bereavement Support 263,410 40,516 303,926
Education and research 667,765 75,550 743,315
8,773,206 1,044,229 9,817,435
Total expenditure 13,223,224 1,598,041 14,821,265
----- End of picture text -----

----- Start of picture text -----
2023 Comparatives
Direct Costs Support Costs Total
Expenditure on raising funds
2023 £ 2023 £ 2023 £
Costs of selling donated goods 2,459,677 261,193 2,720,870
Cost of raising income from donations,
1,353,352 245,198 1,598,550
legacies, trusts and fundraising
-
Investment management fees 31,390 31,390
Cost of wholly owned subsidiary:
-
Purchased goods 39,374 39,374
3,883,793 506,391 4,390,184
Expenditure on charitable activities
Provision of hospice services
In-Patient Care 5,257,315 618,715 5,876,030
Community Care 1,497,380 144,499 1,641,879
Out-Patients 512,982 84,727 597,709
Bereavement Support 259,232 35,425 294,657
Education and research 648,303 70,119 718,422
8,175,212 953,485 9,128,697
Total expenditure 12,059,005 1,459,876 13,518,881
----- End of picture text -----

Trustees’ Report 2023/24

44

7. ANALYSIS OF SUPPORT COSTS

2024 Raising
Funds		 In-Patient
Care		 Community
Care		 Outpatients Bereavement
Support		 Education &
Research		 Total
Governance
~~a~~		 36,938 43,849 10,722 7,336
~~es~~		 2,702 5,039 106,586
Finance
~~ee~~
~~a~~
~~a~~		 64,310
~~ee~~
~~ee~~		 76,341
~~ee~~
~~ee~~		 18,667
~~ee~~
~~ee~~		 12,772
~~ee~~
~~es~~
~~ee~~		 4,705
~~ee~~
~~ee~~		 8,773
~~ee~~
~~ee~~		 185,568
~~ee~~
~~ee~~
IT
~~a~~
~~a~~		 86,432
~~ee~~
~~ee~~		 102,603
~~ee~~
~~ee~~		 25,088
~~ee~~
~~ee~~		 17,166
~~es~~
~~ee~~		 6,323
~~ee~~		 11,791
~~ee~~		 249,403
~~ee~~
HR
~~a~~		 21,966
~~ee~~
~~ee~~		 26,075
~~ee~~
~~ee~~		 6,376
~~ee~~
~~ee~~		 4,362
~~ee~~		 1,607
~~ee~~		 2,997
~~ee~~		 63,383
~~ee~~
Admin 94,232
~~ee ~~		 111,861
~~ee~~		 27,352
~~ee~~		 18,715 6,894
~~ee~~		 12,855
~~ee~~		 271,909
Estates and
Facilities
~~a~~		 220,957
~~ee~~		 262,296
~~ee~~		 64,136
~~ee~~		 43,882
~~ee~~		 16,165
~~ee~~
~~ee~~		 30,142
~~ee~~
~~ee~~		 637,578
~~ee~~
Depreciation
~~pT~~		 28,977
~~pT~~		 34,398
~~pT~~		 8,411
~~pT~~		 5,755
~~pT~~		 2,120
~~ee ~~
~~pT~~		 3,953
~~ee~~
~~pT~~		 83,614
~~pT~~
Total 553,812 657,423 160,752 109,988 40,516 75,550 1,598,041
2023 Raising
Funds		 In-Patient
Care		 Community
Care		 Outpatients Bereavement
Support		 Education &
Research		 Total
Governance
~~a ~~
~~a~~		 35,436
~~a~~		 43,296
~~ss~~		 10,112
~~ss~~		 5,929
~~es~~		 2,479 4,907 102,159
Finance
~~a ee~~
~~a~~		 75,301
~~ee~~
~~ee~~		 92,003
~~ee~~
~~ee es~~		 21,487
~~ee~~
~~es~~		 12,599
~~ee~~
~~es~~		 5,268
~~ee~~		 10,426
~~ee~~		 217,084
~~ee~~
IT
~~a~~		 87,426
~~ee~~		 106,819
~~ee es~~		 24,947
~~es~~
~~Ge~~		 14,628
~~es~~
~~Ge~~		 6,116 12,106 252,042
HR
~~se~~		 14,454
~~ee~~
~~se~~		 17,660
~~ee es~~
~~se~~		 4,124
~~es~~
~~se~~
~~Ge~~		 2,418
~~se~~
~~Ge~~		 1,011
~~se~~		 2,002
~~se~~		 41,669
~~se~~
Admin
~~a~~		 127,550 155,841 36,396
~~Ge~~		 21,341
~~Ge~~		 8,923
~~ee~~		 17,661
~~ee~~		 367,712
Estates and
Facilities
~~a ~~
~~a~~		 139,953
~~a~~
~~ee~~		 170,997
~~ee~~
~~ee~~		 39,936
~~ee~~
~~ee~~		 23,416
~~ee~~
~~ee~~		 9,790
~~ee~~
~~ee~~
~~ee~~		 19,379
~~ee~~
~~ee~~
~~ee~~		 403,471
~~ee~~
~~ee~~
Depreciation
~~a~~		 26,271
~~ee~~		 32,099
~~ee~~		 7,497
~~ee~~		 4,396
~~ee~~		 1,838
~~ee ~~
~~ee~~		 3,638
~~ee~~
~~ee~~		 75,739
~~ee~~
Total 506,391
~~ee~~		 618,715
~~ee~~		 144,499
~~ee~~		 84,727
~~ee~~		 35,425
~~ee~~		 70,119
~~ee ~~		 1,459,876
~~ee~~

The allocation is based upon the headcount in these areas, adjusted for those costs which were only incurred on the Hospice site, being IT, Finance and administration together with a proportion of building and maintenance costs.

Trustees’ Report 2023/24

45

8. NET INCOME/ (EXPENDITURE) FOR THE YEAR

This is stated after charging: 2024 £ 2023 £
Auditor’s Remuneration: -
Fees payable to the charity's auditor for the audit of the charity's annual financial statements 17,745 16,900
Fees payable to the charity's auditor for other services to the group: - -
Taxation services 1,900 1,950
The audit of the charity's subsidiary 3,730 3,550
Reporting to group auditor - 1,100
Depreciation:
On owned fixed assets 363,714 301,348
On leased fixed assets 359,756 350,440
Rental of land and buildings under operating leases 522,360 509,590
Hire of equipment under operating leases 13,746 9,701

9. ANALYSIS OF STAFF COSTS, TRUSTEES REMUNERATION AND EXPENSES AND THE COST OF KEY MANAGEMENT PERSONNEL GROUP AND CHARITY

Aggregate remuneration comprised: 2024 £ 2023 £
Wages and salaries 9,199,405 8,439,019
Social security costs 848,114 817,994
Other pension costs 738,304 671,232
10,785,823 9,928,245

During the year, three ex-gratia payments were made totalling £64,506 (2023: £nil).

The overall average and whole time equivalent (WTE) employees during the period was as follows:

2024 No. 2024 WTE 2023 No. 2023 WTE
Provision of Hospice Services 167 133 170 135
Raising funds 85 71 84 70
Support functions 47 42 47 42
299 246 301 247

Trustees’ Report 2023/24

46

The number of Group employees whose emoluments, excluding pension contributions and employers’ national insurance, but including benefits in kind, were in excess of £60,000 was:

2024 No. 2023 No.
£60,000 - £70,000 1 -
£70,001 - £80,000 1 2
£80,001 - £90,000 2 2
£90,001 - £100,000 1 1
£100,001 - £110,000 2 2
£140,001 - £150,000 - 1
£150,001 - £160,000 1 -

The key management personnel of the parent Charity, listed on page 4, are the same as the Group. The total remuneration (including pension contributions and employers’ national insurance) of the key management personnel of the Group for the year totalled £717k (2023: £724k).

As shown above, St Gemma’s Hospice has employed eight individuals who earned over £60,000. Four of these are medical consultants who are directly employed on NHS equivalent contracts, in line with national agreements. The others are members of the Hospice Leadership team (HLT), responsible for running the Hospice. The Chief Executive is not the highest paid employee.

No trustees received remuneration during the current or prior year. No travel or subsistence expenses were paid to trustees during the current or prior year.

Trustees’ Report 2023/24

47

10. TANGIBLE FIXED ASSETS

----- Start of picture text -----
Improvements Assets Under
Charity and Computer Fixtures and Motor
to Leasehold Construction Total £
Group Cost: Equipment £ Fittings £ Vehicles £
Property £ £
1 April 2023 6,670,892 893,006 4,006,886 212,051 49,732 11,832,567
Additions 15,202 122,195 577,802 7,906 - 723,105
Transfers 219,957 - - (219,957) - -
- -
Disposals (2,997) (12,232) (63,442) (78,671)
31 March 2024 6,903,054 1,002,969 4,521,246 - 49,732 12,477,001
Depreciation:
-
1 April 2023 5,557,765 733,442 2,947,951 36,492 9,275,650
Charge for the -
359,756 107,227 253,177 3,310 723,470
year
Transfers - - - - - -
- -
Disposals (1,349) (12,232) (60,302) (73,883)
31 March 2024 5,916,172 828,437 3,140,826 - 39,802 9,925,237
Net book value:
31 March 2024 986,882 174,532 1,380,420 - 9,930 2,551,764
31 March 2023 1,113,127 159,564 1,058,935 212,051 13,240 2,556,917
----- End of picture text -----

All tangible fixed assets are used for or to support charitable purposes.

11. FIXED ASSET INVESTMENTS

----- Start of picture text -----
Cost Unlisted Listed Total
Charity
£ 2024 £ 2024 £
Cost / market value at 1 April 2 6,248,717 6,248,719
Additions - 5,059,731 5,059,731
-
Disposal proceeds (4,977,985) (4,977,985)
-
Unrealised gains 495,849 495,849
Realised loss - (38,492) (38,492)
-
Decrease in cash deposits (113,752) (113,752)
Cost / market value at 31 March 2024 2 6,674,068 6,674,070
The charity holds a £2 investment in the subsidiary.
Group Listed Valuation £
2024 £ 2023 £
-
Market value at 1 April 6,248,717 6,746,073
Additions - 5,059,731 1,583,281
-
Disposal proceeds (4,977,985) (1,609,777)
-
Unrealised gains 495,849 (318,888)
Realised loss - (38,492) (146,493)
-
Decrease in cash deposits (113,752) (5,479)
Market value at 31 March - 6,674,068 6,248,717
----- End of picture text -----

The unlisted investment represents an investment in a subsidiary undertaking:

Trustees’ Report 2023/24

48

Name of Subsidiary Class of Shares Held Percentage of Shares Held
St Gemma’s Hospice Services Limited Ordinary 100%

St Gemma’s Hospice also holds a minority share in an unlisted investment, Hospice Quality Partnership, which was acquired for £10.

Listed Investments

The historic cost of listed fixed asset investments at 31 March 2024 was £5,963,434 (2023: £5,209,889). The investments are managed by an external fund manager. The funds can be analysed as follows:

2024 £ 2023 £
Fixed interest 696,494 686,345
UK Equities 657,978 2,212,330
Overseas equities 4,495,086 2,467,295
Property 177,112 187,613
Alternative Assets 586,978 520,964
Cash deposits 60,420 174,170
6,674,068 6,248,717

12. DEBTORS

Group Group Charity Charity
Amounts falling due within one year: 2024 £ 2023 £ 2024 £ 2023 £
Trade debtors 12,215 18,732 - -
Amounts due from subsidiary undertaking - - 8,753 32,762
Income tax recoverable 69,414 92,676 69,414 92,676
Other debtors 402,770 1,931,339 402,770 1,931,339
Prepayments 224,181 168,573 224,181 168,573
708,580 2,211,320 705,118 2,225,350

Trustees’ Report 2023/24

49

13. CREDITORS: amounts falling due within one year

Group Group Charity Charity
2024 £ 2023 £ 2024 £ 2023 £
Trade creditors 17,301 19,196 - -
Other creditors 652,341 688,781 652,342 688,783
Accruals and deferred income 505,395 1,522,360 505,395 1,522,360
1,175,037 2,230,337 1,157,737 2,211,143

Included in Other Creditors is £226,059 (2023: £284,849) received by St Gemma’s in the role of host of the Leeds Palliative Care Network, which involves collaborative working with other palliative and end of life care providers in Leeds.

14. DEFERRED INCOME

Group Group Charity Charity
2024 £ 2023 £ 2024 £ 2023 £
Brought forward 1,297,766 91,053 1,297,766 91,053
Deferred income 188,251 1,287,166 188,251 1,287,166
Release in year (1,278,879) (80,453) (1,278,879) (80,453)
Carried forward 207,138 1,297,766 207,138 1,297,766

The deferred income figure includes £18,886 (2023: £20,475) for monies received to support our Academic Unit of Palliative Care in the delivery of the CNS ECHO project. £nil (2023: £1,126,107) has been received from West Yorkshire ICB for care of patients. In addition, £17,884 (2023: £32,484) has been received in advance for training courses delivered by the Academic Unit of Palliative Care. £134,707 (2023: £118,699) has been received for the provision of an Inclusion Service. £5,515 (2023: £nil) has been received for the Winter Ball 2024.

Trustees’ Report 2023/24

50

15. COMPARATIVE CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES

----- Start of picture text -----
Unrestricted Designated Restricted 31 March 2023
Income from Notes
Funds £ Funds £ Funds £ Total Funds £
Donations, legacies and trusts 2 4,417,622 - 249,220 4,666,842
Other trading activities
- -
Sale of donated goods 4,050,961 4,050,961
- -
Fundraising 606,717 606,717
- -
Lottery 348,911 348,911
- -
Commercial trading operations 49,953 49,953
3 5,056,542 - - 5,056,542
Charitable activities – Provision
of Hospice Services:
- -
WY ICB Funding 4,279,346 4,279,346
Additional WY ICB income 272,452 - - 272,452
LPCN income 182,499 - - 182,499
- -
Controlled drugs income 66,788 66,788
- -
Other grants 27,535 27,535
Education and research 146,322 - - 146,322
Bistro 71,912 - - 71,912
Other 94,024 - - 94,024
4 5,113,343 - 27,535 5,140,878
Investments Income 5 195,036 - - 195,036
Total income 14,782,543 - 276,755 15,059,298
Expenditure on
Raising funds
-
Cost of selling donated goods 2,651,691 69,179 2,720,870
Cost of raising income from
-
donations, legacies, trusts 1,551,942 46,608 1,598,550
and fundraising
- -
Investment management fees 31,390 31,390
- -
Commercial trading operations 39,374 39,374
-
4,274,397 115,787 4,390,184
Charitable activities -
8,338,285 605,495 184,917 9,128,697
Provision of Hospice Services
Total expenditure 6 12,612,682 721,282 184,917 13,518,881
Net income/(expenditure)
8 2,169,861 (721,282) 91,838 1,540,417
before investment (losses)/gains
Net (losses)/gains on investments 11 (465,381) - - (465,381)
Net income /(expenditure) 1,704,480 (721,282) 91,838 1,075,036
Transfer between funds 16/17 (735,289) 961,667 (226,378) -
Net movement in funds 969,191 240,385 (134,540) 1,075,036
Reconciliation of funds:
Total funds brought forward 10,246,759 3,648,990 268,217 14,163,966
Net movement in funds for the year 969,191 240,385 (134,540) 1,075,036
Total funds carried forward 16/17 11,215,950 3,889,375 133,677 15,239,002
----- End of picture text -----

Trustees’ Report 2023/24

51

16. UNRESTRICTED FUNDS

----- Start of picture text -----
Income &
1 April Expenditure/ 31 March
Charity and Group net gain on Transfers £
2023 £ Gains £ 2024 £
investments £
Designated Funds
Research facilitator 52,934 - - - 52,934
- -
Maintenance and gardens 262,356 (189,168) 73,188
- -
Buildings Development 214,174 (89,977) 124,197
Service Transformation 201,311 - (77,614) - 123,697
-
Digital Development 571,074 (34,988) (71,422) 464,664
COVID Response 30,609 - - - 30,609
AUPC Strategy - - - 500,000 500,000
Buildings Upgrade - - - 2,000,000 2,000,000
Fixed assets 2,556,917 - (649,587) 644,434 2,551,764
-
3,889,375 (762,189) 2,793,867 5,921,053
General Fund 11,215,950 14,335,852 (13,976,724) (2,768,954) 8,806,124
Total unrestricted funds 15,105,325 14,335,852 (14,738,913) 24,913 14,727,177
----- End of picture text -----

The maintenance and Gardens fund is for ongoing building maintenance work to ensure that the Hospice is kept to the highest possible standard. The fixed asset fund represents reserves invested in fixed assets and each year a transfer is made equivalent to the value of additions in the year.

In 2023/24 we appointed a Research Practitioner, funded by the National Institute for Health Research to further embed and develop our research portfolio in the Hospice. The Digital Development Reserve and COVID Response Reserve were created in 2021 to support the Transformation Programme. An additional £500,000 was added to allow for the continued upgrade programme of IT and telephony infrastructure and to enhance IT skills across the Hospice in 2023.

The Buildings Development Reserve represents a commitment from the Sisters of the Cross and Passion to transform and integrate the convent into the current estate. Two new reserves were created in 2024: The AUPC Strategy Reserve will support the commercialisation of the AUPC; and the Buildings Upgrade Reserve will support the initial site development requirements of the current facilities. The Service Transformation fund is designated to support ongoing service development needs of the Hospice.

The transfers represent expenditure on capital items within the different designated funds.

YEAR ENDED MARCH 2023 COMPARATIVES

----- Start of picture text -----
Income &
1 April Expenditure/ 31 March
Charity and Group net gain on Transfers £
2022 £ Gains £ 2023 £
investments £
Designated Funds
Research Facilitator - - - 52,934 52,934
Maintenance 312,836 - - (50,480) 262,356
- -
Buildings Development 304,641 (90,467) 214,174
Service Transformation 257,175 - (55,864) - 201,311
Digital Development 171,558 - (5,298) 404,814 571,074
- -
COVID Response 38,941 (8,332) 30,609
Fixed assets 2,563,839 - (651,788) 644,866 2,556,917
-
3,648,990 (721,282) 961,667 3,889,375
General Fund 10,246,759 14,317,162 (12,612,682) (735,289) 11,215,950
Total unrestricted funds 13,895,749 14,317,162 (13,333,964) 226,378 15,105,325
----- End of picture text -----

Trustees’ Report 2023/24

52

17. RESTRICTED FUNDS

----- Start of picture text -----
1 April 31 March
Charity and Group Income £ Expenditure £ Transfers £
2023 £ 2024 £
City wide education programme 10,550 - - - 10,550
Postage costs – restricted
20,873 25,000 (16,248) - 29,625
donation
Training and Education 63,162 - - - 63,162
Restricted Trust Income 20,714 70,481 (56,425) (20,913) 13,857
-
Sundry restricted donations 12,650 (4,500) (4,000) 4,150
Mental Health Clinical Nurse
18,378 - (5,179) - 13,199
Specialist
Total Restricted Funds 133,677 108,131 (82,352) (24,913) 134,543
----- End of picture text -----

The Citywide education programme was set up to improve the provision of palliative care across the city.

The competency framework for nursing staff was funded by WY ICB. Health Education England provided funding to support the End-of-Life Care Outcomes project being undertaken within the Academic Unit of Palliative Care.

The Mental Health Clinical Nurse Specialist is funded by West Yorkshire ICB.

The transfers represent expenditure on capital items within the different restricted funds.

YEAR ENDED MARCH 2023 COMPARATIVES

----- Start of picture text -----
31 March
Charity and Group 1 April 2022 £ Income £ Expenditure £ Transfers £
2023 £
NHSE Covid funding - 27,535 (27,535) - -
Restricted legacy – Dales ward - 5,000 (5,000) - -
City wide education programme 10,667 - (117) - 10,550
Dedicated space Young - - -
57,357 (57,357)
People's service-WY ICB
Dedicated space Young - -
41,000 50,000 (91,000)
People's service-donation
Postage costs – restricted -
16,181 25,000 (20,308) 20,873
donation
Training and Education 63,162 52,934 (52,934) - 63,162
Restricted Trust Income 58,723 110,371 (70,359) (78,021) 20,714
Sundry restricted donations 225 5,915 (6,140) - -
Mental Health Clinical Nurse
- -
20,902 (2,524) 18,378
Specialist
Total Restricted Funds 268,217 276,755 (184,917) (226,378) 133,677
----- End of picture text -----

Trustees’ Report 2023/24

53

18. ANALYSIS OF NET ASSETS BETWEEN FUNDS

----- Start of picture text -----
Charity Unrestricted Funds £ Designated Funds £ Restricted Funds £ 2024 Total £
Tangible assets - 2,551,764 - 2,551,764
Investments 6,674,070 - - 6,674,070
Current assets 3,289,791 3,369,289 134,543 6,793,623
Current liabilities (1,157,737) - - (1,157,737)
Total net assets 8,806,124 5,921,053 134,543 14,861,720
Group Unrestricted Funds £ Designated Funds £ Restricted Funds £ 2024 Total £
Tangible assets - 2,551,764 - 2,551,764
Investments 6,674,068 - - 6,674,068
Current assets 3,307,093 3,369,289 134,543 6,810,925
Current liabilities (1,175,037) - - (1,175,037)
Total net assets 8,806,124 5,921,053 134,543 14,861,720
----- End of picture text -----

2023 Comparatives

----- Start of picture text -----
Charity Unrestricted Funds £ Designated Funds £ Restricted Funds £ 2023 Total £
Tangible assets - 2,556,917 - 2,556,917
Investments 6,248,719 - - 6,248,719
Current assets 7,178,374 1,332,458 133,677 8,644,509
Current liabilities (2,211,143) - - (2,211,143)
Total net assets 11,215,950 3,889,375 133,677 15,239,002
Group Unrestricted Funds £ Designated Funds £ Restricted Funds £ 2023 Total £
Tangible assets - 2,556,917 - 2,556,917
Investments 6,248,717 - - 6,248,717
Current assets 7,197,574 1,332,458 133,677 8,663,705
Current liabilities (2,230,337) - - (2,230,337)
Total net assets 11,215,950 3,889,375 133,677 15,239,002
----- End of picture text -----

19. NOTES TO THE CASHFLOW STATEMENT

----- Start of picture text -----
Reconciliation of net incoming resources to net cashflow from operating 2024 £ 2023 £
activities
Net income/(Net deficit) for the reporting period (377,282) 1,075,036
Investment income (313,834) (195,036)
Depreciation 723,470 651,788
Losses/(gains) on investments (457,357) 465,381
Decrease in stock 3,329 1,482
(Increase)/decrease in debtors 1,502,740 (891,681)
Increase/(decrease) in creditors (1,055,300) 923,246
Net cash inflow from operating activities 25,766 2,030,216
----- End of picture text -----

Trustees’ Report 2023/24

54

20. FINANCIAL COMMITMENTS

At the balance sheet date the total future minimum lease payments under non-cancellable operating leases:

Land & Buildings Land & Buildings Other Other
2024 £ 2023 £ 2024 £ 2023 £
Within one year 417,458 416,318 12,271 9,401
Between one and five years 958,417 831,042 18,233 19,461
1,375,875 1,247,360 30,504 28,862

21. PENSION COMMITMENTS

The Hospice contributes to two pension schemes. A defined benefit scheme operated by the National Health Service Superannuation Scheme, which is only available to staff who have previously contributed to the scheme. The administration of the scheme is dealt with by the National Health Service Pension agencies. Contributions to this scheme are paid in respect of current service, and there is no liability to the Hospice in respect of past service. In addition, there is a Group Personal Pension Scheme, which is a defined contribution pension scheme, administered by Standard Life, which is available to all employees.

The charge to the Statement of Financial Activities of £738,304 (2023: £671,232) represents contributions to the funds during the period. Contributions payable to the schemes at the year end date totalling £43,452 (2023: £40,862) are included in creditors.

22. RELATED PARTIES

Control

Throughout the period, St Gemma’s Hospice was ultimately controlled by the Congregation of the Sisters of the Cross and Passion of our Lord Jesus Christ. The members of the company all belong to this congregation.

Transactions

The Congregation retains freehold title to the Hospice which is let to the company on a long term lease for peppercorn rent.

Trustee donations

The aggregate amount of cash donations received from Trustees during the year was £5,195 (2023: £25).

Trustee relationships

Schofield Sweeney has provided legal advice in relation to the Hospice’s lease arrangements. Chris Schofield (Trustee – resigned 30th September 2023) is Chairman of Schofield Sweeney.

23. JOINT ARRANGEMENT

St Gemma’s Hospice has an arrangement with Sue Ryder Wheatfields to operate a joint lottery for fundraising purposes, which is administered by Sterling Lotteries.

The income received during the year from this lottery was £76,144 (2023: £81,752) and is included in note 3.

Trustees’ Report 2023/24

55

St Gemma’s Hospice is a local, independent charity, providing expert medical and nursing care to thousands of local people every year – all free of charge to patients and their families. If you would like more information about our work, please contact us:

St Gemma’s Hospice 329 Harrogate Road Moortown Leeds, LS17 6QD

www.twitter.com/stgemmashospice www.facebook.com/st.g.hospice

www.linkedin.com/company/st-gemma-s-hospice

Website: www.st-gemma.co.uk Email: hello@st-gemma.co.uk Reception: 0113 218 5500

Company Registration No: 02773867 Charity Registration No: 1015941

Registered Charity No. 1015941 Trustees’ Report Quality Acc Part One I Overview unt 2023/242016/201756

56